Sunmax Biotechnology Co., Ltd. (TPEX:4728)

Sunmax Biotechnology Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	21,676	15,250	11,110	7,407	4,499	4,384
Market Cap Growth	41.64%	37.26%	50.00%	64.65%	2.61%	0.37%
Enterprise Value	21,064	14,751	10,469	6,785	3,756	3,685
Last Close Price	398.00	272.27	191.22	122.37	71.74	68.23
PE Ratio	30.27	22.45	17.76	13.88	18.31	18.42
PS Ratio	10.85	8.39	6.58	5.29	4.34	5.12
PB Ratio	15.01	10.08	7.79	5.59	4.39	4.93
P/TBV Ratio	15.09	10.12	7.82	5.61	4.41	4.96
P/FCF Ratio	27.79	28.82	15.00	15.12	-	17.05
P/OCF Ratio	26.90	27.18	13.09	11.49	18.49	11.33
EV/Sales Ratio	10.55	8.11	6.20	4.85	3.63	4.31
EV/EBITDA Ratio	19.38	14.83	11.18	8.47	9.45	10.66
EV/EBIT Ratio	21.37	15.91	11.70	8.84	10.22	11.09
EV/FCF Ratio	27.01	27.88	14.13	13.85	-	14.33
Debt / Equity Ratio	0.09	0.10	0.12	0.05	0.10	0.15
Debt / EBITDA Ratio	0.11	0.14	0.17	0.08	0.23	0.35
Debt / FCF Ratio	0.16	0.27	0.23	0.13	-	0.51
Asset Turnover	1.06	0.86	0.86	0.85	0.73	0.69
Inventory Turnover	2.78	2.70	3.39	3.23	3.53	4.65
Quick Ratio	3.08	2.72	2.12	2.52	2.06	3.12
Current Ratio	3.86	3.32	2.36	2.78	2.36	3.28
Return on Equity (ROE)	51.00%	46.24%	45.48%	45.45%	25.69%	30.41%
Return on Assets (ROA)	32.72%	27.24%	28.30%	29.29%	16.12%	16.77%
Return on Capital (ROIC)	39.88%	35.62%	37.49%	38.23%	21.44%	22.92%
Return on Capital Employed (ROCE)	59.50%	52.50%	52.60%	52.30%	31.90%	31.10%
Earnings Yield	3.31%	4.46%	5.63%	7.21%	5.46%	5.43%
FCF Yield	3.60%	3.47%	6.67%	6.62%	-0.22%	5.86%
Dividend Yield	2.91%	4.26%	5.75%	7.76%	6.13%	2.93%
Payout Ratio	88.12%	88.18%	82.69%	44.89%	44.34%	34.31%
Buyback Yield / Dilution	-0.01%	-0.00%	0.01%	-0.03%	0.02%	0.00%
Total Shareholder Return	2.97%	4.26%	5.76%	7.74%	6.16%	2.93%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.